Aug 2, 2021 · If you have Type 2 diabetes or obesity, GLP-1 agonists might be a helpful part of your treatment plan. Learn more.

Apr 6, 2026 · GLP-1 agonist drugs treat diabetes by balancing blood glucose levels. Here’s our list of GLP-1 agonists, how they work, similarities and differences, and more.

Dec 1, 2025 · To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) …

Mar 12, 2026 · These challenges raise safety issues, including treatment delay or interruption, lack of regulatory oversight for alternatively sourced agents, and dosing errors. Treatment interruption and …

Apr 15, 2026 · 1. The Current Standard (2024–2026): GLP-1 and Dual Incretin Therapies The foundation of modern obesity pharmacotherapy is built on incretin-based drugs. GLP-1 Receptor …

Apr 1, 2026 · Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 …

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review examines their expanding role, evaluating …

Oct 15, 2025 · Learn everything you need to know about GLP-1 medications, including how they work, benefits for weight loss and Type 2 diabetes, side effects and important safety considerations. Get …

Dec 1, 2025 · This Special Communication summarizes the WHO guideline on the management of obesity with GLP-1 therapies in adults and calls on nations to ensure equitable access to obesity …

Apr 15, 2026 · It's quite common for people to start on GLP-1 drugs like Ozempic and Zepbound, especially as the diabetes and obesity treatments become more ubiquitous. They're designed to treat …